CHR Metz-Thionville Hopital de Mercy — Metz

Public research footprint of CHR Metz-Thionville Hopital de Mercy, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

End Stage Chronic Renal Failure · Intensive Care Unit · Pseudophakic Bullous Keratopathy · Double-filtration Plasmapheresis

Recently updated registry entries

NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)
NCT07738887 — Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia… (Not Yet Recruiting)
NCT07625033 — Risk Factors of Atrial Fibrillation After Cardiac Surgery (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHR Metz-Thionville Hopital de Mercy?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.